NxStage Medical, Inc.NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...

NxStage Medical, Inc.NXTM announced that its Nx2me Connected Health (remote patient management system) reduces home hemodialysis technique failure or conversion to in-center hemodialysis by 29%.

NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, ...

Please provide your email address to receive an email when new articles are posted on . ATLANTA – NxStage Medical Inc. introduced a new patient outreach campaign at the Annual Dialysis Conference, ...

NxStage Medical (NASDAQ: NXTM) has revolutionized the way that dialysis patients receive treatment, with its home-dialysis devices offering a much more convenient alternative to visiting outpatient ...

WALTHAM, Mass., Sept. 4, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), a global leader in kidney care, has achieved a growth milestone of more than 14,000 U.S.-based patients using the Company's ...

Please provide your email address to receive an email when new articles are posted on . NxStage Kidney Care Inc., a subsidiary of NxStage Medical Inc., today announced the opening of its dialysis ...

Fresenius SE & Co.'s minority-owned kidney dialysis business agreed Monday to acquire NxStage Medical Inc. for about $2 billion as part of the German health-care provider's broader push into the U.S.